Wrap Technologies Secures $4.5M in Private Placement to Accelerate Emerging Counter-Drone Technologies and Dual-Use Go-to-Market Strategy
Key Financing Highlights:
Accelerates Counter-UAS Fielding: Proceeds are expected to advance Wrap's recently announced Wrap-Merlin and Wrap-PANDA programs, which repurpose existing BolaWrap® 150 inventory into new counter-drone capabilities, enabling rapid progression from development to field application.
Dual-Use Pathway: Supports both Wrap's continued law enforcement go-to-market strategy and near-term commercial wins in federal sales, where counter-UAS demand is accelerating. Wrap believes this "dual use" model positions Wrap to leverage its existing technology base while building a scalable federal government business through primes and strategic Department of Defense (DoD) and Department of Homeland Security (DHS) offices.
Expands Market Execution: In parallel, the financing is expected to strengthen Wrap's law enforcement growth initiatives, including subscription-based solutions (WrapReady and WrapPlus) and its ecosystem of public safety technologies (BolaWrap 150, WrapVision, and WrapReality).
WrapVision Expansion: Funds are also expected to advance WrapVision's offering of North American–made body cameras through third-party partnerships, while building out cost-saving technologies in data processing, migration, and storage—addressing major cost pain points for law enforcement agencies and opening access to adjacent markets such as healthcare where current solutions remain economically prohibitive.
MIAMI, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (NASDAQ:WRAP) ("Wrap" or, the "Company"), a recognized innovator in public safety technology, today announced that it has executed a securities purchase agreement with certain accredited and institutional investors in a private placement for the purchase and sale of (i) an aggregate of 4,500 shares of the Company's Series B Preferred Stock, with a stated value of $1,000 per share, convertible into an aggregate of 3,000,000 shares of common stock of the Company at an initial conversion price of $1.50 per share, and (ii) accompanying warrants to purchase up to 3,000,000 shares of common stock, for aggregate gross proceeds of $4.5 million. The conversion of the preferred stock and the exercise of the accompanying warrants are subject to stockholder approval.
The warrants will have an initial exercise price of $1.50 per share, subject to adjustment, and will expire five years from the date of stockholder approval.
The closing of the private placement is subject to customary closing conditions and is expected to occur on or around August 19, 2025. The Company intends to use the net proceeds of the offering for working capital and general corporate purposes.
The securities in the private placement offering were offered and sold in transactions exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), pursuant to the exemption for transactions ...
